RCAMU
PBH icon

Rothschild & Co Asset Management US’s Prestige Consumer Healthcare PBH Stock Holding History

Rothschild & Co Asset Management US’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$16.1M Sell
256,594
-16,688
-6% -$957K 0.24% 80
2022
Q3 		$13.6M Sell
273,282
-7,807
-3% -$432K 0.23% 84
2022
Q2 		$16.5M Buy
281,089
+16,914
+6% +$932K 0.25% 80
2022
Q1 		$14M Buy
+264,175
New +$15.3M 0.18% 107

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rothschild & Co Asset Management US's PBH Position: Q4 2022 in Review

Rothschild & Co Asset Management US reduced its Prestige Consumer Healthcare (PBH) stake by 6.1% in Q4 2022, selling an estimated $957K and leaving 256,594 shares worth $16.1M. The position accounts for 0.24% of the portfolio, ranked #80.

Rothschild & Co Asset Management US first reported a position in PBH in Q1 2022 and has held it in 4 quarters since. The position peaked at $16.5M in Q2 2022. 289 funds tracked by Wall St. Rank hold PBH as of Q4 2022.

  • Rothschild & Co Asset Management US held 256,594 shares of Prestige Consumer Healthcare worth $16.1M as of Q4 2022.
  • Rothschild & Co Asset Management US sold 16,688 Prestige Consumer Healthcare shares in Q4 2022, an estimated $957K.
  • Prestige Consumer Healthcare made up 0.24% of Rothschild & Co Asset Management US's portfolio in Q4 2022, its #80 holding.
  • Rothschild & Co Asset Management US first reported a position in Prestige Consumer Healthcare in Q1 2022 and has held it in 4 quarters since.
  • Rothschild & Co Asset Management US's Prestige Consumer Healthcare position peaked at $16.5M in Q2 2022.
  • 289 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2022.

Based on Rothschild & Co Asset Management US's 13F filing for Q4 2022, filed 14 Feb 2023.